Verano Holdings (VRNO) Net Cash Flow (2021 - 2026)
Verano Holdings' (VRNO) quarterly Net Cash Flow came in at -$8.7 million in Q1 2026, down 143.23% year-on-year from $20.1 million in Q1 2025, and down 8463.46% on a QoQ basis from $104000.0 in Q4 2025.
Verano Holdings (VRNO) Net Cash Flow (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Net Cash Flow data on file, last reported at -$8.7 million in Q1 2026.
- On a quarterly basis, Net Cash Flow fell 143.23% year-over-year to -$8.7 million in Q1 2026; TTM through Mar 2026 was -$10.2 million, a 90.7% increase from a year earlier, with the FY2025 full-year figure at -$5.1 million, up 94.17% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$8.7 million, down from $104000.0 in the prior quarter.
- Over the last five years, Net Cash Flow for VRNO reached as high as $44.8 million in Q4 2023 and fell as low as -$65.1 million in Q3 2024.
- Historically, Net Cash Flow has averaged -$1.5 million across 5 years, with a median of $7.4 million in 2023.
- Across the five-year window, Net Cash Flow soared 424.81% in 2023 and tumbled 955.78% in 2024, its largest moves.
- Year by year, Net Cash Flow stood at $8.5 million in 2022, then surged by 424.81% to $44.8 million in 2023, then slumped by 49.13% to $22.8 million in 2024, then plunged by 99.54% to $104000.0 in 2025, then slumped by 8463.46% to -$8.7 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$8.7 million in Q1 2026, $104000.0 in Q4 2025, and $14.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | -8.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.70 Mn |
| Mar 31, 2026 | -8.70 Mn |
| Dec 31, 2025 | 104,000.00 |
| Dec 31, 2025 | 104,000.00 |
| Sep 30, 2025 | 14.05 Mn |
| Sep 30, 2025 | 14.05 Mn |
| Jun 30, 2025 | -15.65 Mn |
| Jun 30, 2025 | -15.65 Mn |
| Mar 31, 2025 | -3.58 Mn |
| Mar 31, 2025 | -3.58 Mn |
| Dec 31, 2024 | 22.81 Mn |
| Dec 31, 2024 | 22.81 Mn |
| Sep 30, 2024 | -65.07 Mn |
| Sep 30, 2024 | -65.07 Mn |
| Jun 30, 2024 | -63.75 Mn |
| Jun 30, 2024 | -63.75 Mn |
| Mar 31, 2024 | 19.02 Mn |
| Mar 31, 2024 | 19.02 Mn |
| Dec 31, 2023 | 44.84 Mn |
| Dec 31, 2023 | 44.84 Mn |